|
|
|
|
|
|
|
|
|
The Wright Reports site is no longer hosted or operated by Manta. Please review
the following:
1. You have been redirected to CorporateInformation.com where you can view
Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to
www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on
to the member site:
http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact
help@corporateinformation.com, Contact phone nr to be provided later)
|
|
|
|
|
|
 |
|
|
|
|
|
|
 |
|
Matrix Laboratories Limited
Company Snapshot
|
|
Business Description:
Matrix Laboratories Limited operates in the Pharmaceutical preparations sector. Matrix Laboratories Limited is a manufacturer and supplier of active pharmaceutical ingredients (APIs) for a range of therapeutic categories, including antibacterials, central nervous system agents, antihistamine/anti-asthmatics, cardiovasculars, antivirals, antidiabetics, antifungals, proton pump inhibitors and pain management drugs. Anti Bacterials include Ciprofloxacin, Gatifloxacin, Norfloxacin, and Levofloxacin Hemihydrate. As of March 31, 2011, it held 40% equity interest in Matrix Laboratories BVBA, Belgium through its wholly owned subsidiary Matrix Laboratories BV, Netherlands. The Company's three principal products include Valacyclovir, Citalopram and Teno Lami 300 milligram/300 milligram. On March 16, 2011, Shanghai Fine Source Company Ltd. was liquidated. During the fiscal year ended March 31, 2011 (fiscal 2011), the Company acquired a finished dosage form (FDF) manufacturing facility at Aurangabad. The Company is a subsidiary of Mylan Inc.
|
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (8/13/2009):
209.35
(Figures in
Indian Rupees) |
|
1 Week |
n/a |
|
13 Weeks |
n/a |
|
|
|
|
|
|
|
|
|
4 Weeks |
n/a |
|
52 Weeks |
n/a |
|
|
|
| |
| |
Matrix Laboratories Limited
Key Data: |
|
|
|
| |
Ticker: |
524794 |
Country: |
INDIA |
| |
|
| |
Exchanges: |
BOM |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Ethical Drug Manufacturers |
| |
|
| |
2010
Sales |
27,768,200,000
(Year Ending Jan 2011). |
Employees: |
3,005 |
| |
|
| |
Currency: |
Indian Rupees |
Market Cap: |
32,729,530,083 |
| |
|
| |
Fiscal Yr Ends: |
March |
Shares Outstanding: |
156,338,811 |
| |
|
| |
Share Type: |
Ordinary |
Closely Held Shares: |
117,707,365 |
|
| |
|
| |
| |
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|
|